Protagonist Therapeutics, Inc. Skyrocketed
Wed, Dec 04, 2019 at 05:30 PM
Protagonist Therapeutics, Inc. (PTGX:NASDAQ) shot up at $8.11, representing a gain of 72.9%. On Tue 03 Dec 19, PTGX:NASDAQ touched a New 2-Week Low of $4.69. The stock got featured on our News Catalysts scanner on Wed 04 Dec 19 at 10:56 AM in the 'BIOTECH' category. From Tue 12 Nov 19, the stock recorded 35.71% Up Days and 33.33% Green Days
About Protagonist Therapeutics, Inc. (PTGX:NASDAQ)
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.
Top 10 Gainers:
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 72.92%
- iBio, Inc. (IBIO:NYSEMKT), 51.06%
- Kodiak Sciences Inc. (KOD:NASDAQ), 49.21%
- Allakos Inc. (ALLK:NASDAQ), 43.56%
- Jason Industries, Inc. (JASN:NASDAQ), 41.44%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 28.39%
- Comstock Mining Inc. (LODE:NYSEMKT), 27.71%
- Obsidian Energy Ltd. (OBE:NYSE), 22.55%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 21.7%
- Neurotrope, Inc. (NTRP:NASDAQ), 21.3%